Guideline: LNDTA Guidelines (Lithuania): Difference between revisions
From Beacon
m (Victor moved page LNDTA Guidelines (Lithuania) to Guideline: LNDTA Guidelines (Lithuania)) |
No edit summary |
||
| Line 1: | Line 1: | ||
<span style="display:none">forproviders</span> <span style="display:none">forpolicymakers</span> | <span style="display:none">forproviders</span> <span style="display:none">forpolicymakers</span> | ||
<span style="display:none">lithuaniacountry</span> | |||
Go back to [[Lithuania]] page | Go back to [[Lithuania]] page | ||
Revision as of 14:54, 4 December 2025
Go back to Lithuania page
Sponsor, manager or home institution: Lietuvos nefrologijos, dializės ir transplantacijos asociacijos.
Primary purpose: To prepare recommendations on how to optimize the diagnosis and treatment of kidney diseases.
Type of information: Recommendations, diagnosis, monitoring, evaluation and treatments of kidney diseases. Click here to learn more.
Cancer areas of interest: C64-C68: Urinary system cancers. Click here to learn more.
Access to information: Click here to access.
